Targeting the entrance channel of NNIBP: Discovery of diarylnicotinamide 1,4-disubstituted 1,2,3-triazoles as novel HIV-1 NNRTIs with high potency against wild-type and E138K mutant virus.

about

Targeting the entrance channel of NNIBP: Discovery of diarylnicotinamide 1,4-disubstituted 1,2,3-triazoles as novel HIV-1 NNRTIs with high potency against wild-type and E138K mutant virus.

Item

http://www.wikidata.org/entity/Q52596192

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Targeting the entrance channel ...... d-type and E138K mutant virus.

@en

Targeting the entrance channel ...... d-type and E138K mutant virus.

@nl

type

Item

label

Targeting the entrance channel ...... d-type and E138K mutant virus.

@en

Targeting the entrance channel ...... d-type and E138K mutant virus.

@nl

prefLabel

Targeting the entrance channel ...... d-type and E138K mutant virus.

@en

Targeting the entrance channel ...... d-type and E138K mutant virus.

@nl

P1476

Targeting the entrance channel ...... ld-type and E138K mutant virus

@en

P2093

Chin-Ho Chen

http://www.w3.org/2001/XMLSchema#string

Dongwei Kang

http://www.w3.org/2001/XMLSchema#string

Heng Zhang

http://www.w3.org/2001/XMLSchema#string

Jinghan Liu

http://www.w3.org/2001/XMLSchema#string

Kuo-Hsiung Lee

http://www.w3.org/2001/XMLSchema#string

Peng Zhan

http://www.w3.org/2001/XMLSchema#string

Xinyong Liu

http://www.w3.org/2001/XMLSchema#string

Ye Tian

http://www.w3.org/2001/XMLSchema#string

Zhaoqiang Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Phenylethylthiazolylthiourea (PETT) non-nucleoside inhibitors of HIV-1 and HIV-2 reverse transcriptases. Structural and biochemical analyses

Crystal structures of HIV-1 reverse transcriptase with etravirine (TMC125) and rilpivirine (TMC278): implications for drug design

Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds

The PETT series, a new class of potent nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase

Characterization of the E138K resistance mutation in HIV-1 reverse transcriptase conferring susceptibility to etravirine in B and non-B HIV-1 subtypes.

Discovery of bioactive molecules from CuAAC click-chemistry-based combinatorial libraries.

First discovery of novel 3-hydroxy-quinazoline-2,4(1H,3H)-diones as specific anti-vaccinia and adenovirus agents via 'privileged scaffold' refining approach.

Combination therapies, effectiveness, and adherence in patients with HIV infection: clinical utility of a single tablet of emtricitabine, rilpivirine, and tenofovir.

Evaluation of Drug-Drug Interactions between Direct-Acting Anti-Hepatitis C Virus Combination Regimens and the HIV-1 Antiretroviral Agents Raltegravir, Tenofovir, Emtricitabine, Efavirenz, and Rilpivirine

Betulinic acid derivatives as human immunodeficiency virus type 2 (HIV-2) inhibitors.

P304

339-350

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EJMECH.2018.03.059

http://www.w3.org/2001/XMLSchema#string

P478

151

http://www.w3.org/2001/XMLSchema#string

P50

Erik De Clercq

Christophe Pannecouque

Dirk Daelemans

Boshi Huang

P577

2018-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29635166

http://www.w3.org/2001/XMLSchema#string

P932

6001364

http://www.w3.org/2001/XMLSchema#string